Watch List: Nokia Corporation (ADR) (NYSE:NOK), New Source Energy Partners LP (NYSE:NSLP), Amgen, Inc. (NASDAQ:AMGN), Agios Pharmaceuticals (NASDAQ:AGIO)

Posted by on Apr 24, 2014

Nokia Corporation (ADR) (NYSE:NOK) officially communicated to its workers that the Chennai facility will become a contract manufacturing unit for Microsoft, which agreed to buy Nokia’s devices and services businesses globally, for Euro 5.44 billion. The development comes on the backdrop of Nokia’s inability to transfer the facility before April 25, the deadline was set to transfer the assets, due to Income Tax dispute. Nokia Corporation (ADR) (NYSE:NOK) shares after opening at $7.39 moved to $7.39 on last trade day and at the end of the day closed at $7.30 . Company price to sales ratio in past twelve months was calculated as 0.78 and price to cash ratio as 3.64. Nokia Corporation (ADR) (NYSE:NOK) showed a positive weekly performance of 2.10%.

New Source Energy Partners LP (NYSE:NSLP) made a public offering of 2,800,000 common units representing limited partner interests, the company said April 22. New Source Energy Partners LP (NYSE:NSLP) shares fell -5.39% in last trading session and ended the day on $23.50. NSLP return on equity ratio is recorded as 19.80% and its return on assets is 10.90%. New Source Energy Partners LP (NYSE:NSLP) yearly performance is 23.55%.

Amgen, Inc. (NASDAQ:AMGN) fell 5.3% during mid-day trading on Wednesday following a weaker than expected earnings announcement,American Banking & Market News reports. Amgen, Inc. (NASDAQ:AMGN) shares moved down -5.02% in last trading session and was closed at $113.32 while trading in range of $111.51 – $116.45 – Amgen, Inc. (NASDAQ:AMGN) year to date (YTD) performance is -0.16%.

Agios Pharmaceuticals Inc. (NASDAQ:AGIO) announced the pricing of its underwritten public offering of 2000000 shares of its common stock at a public offering price of $44.00 per share before underwriting discounts. All of the shares in the offering are to be sold by Agios. In addition Agios has granted the underwriters a 30-day option to purchase up to an additional 300000 shares of common stock at the public offering price less the underwriting discount. Agios Pharmaceuticals Inc (NASDAQ:AGIO) weekly performance is 15.85%. On last trading day company shares ended up $46.34. Agios Pharmaceuticals Inc (NASDAQ:AGIO) distance from 50-day simple moving average (SMA50) is 21.07%. Analysts mean target price for the company is $58.67.

Leave a Reply

Your email address will not be published. Required fields are marked *